SEC Company Response from Hoth Therapeutics, Inc. (HOTH) (CIK 0001711786) (RKTO) — Mar 9, 2020
Hoth Therapeutics, Inc. (HOTH) (CIK 0001711786)
Date: March 9, 2020 · CIK: 0001711786 · Accession: 0001213900-20-005745
AI Filing Summary & Sentiment
File numbers found in text: 333-236887
Show Raw Text
CORRESP
1
filename1.htm
Hoth Therapeutics, Inc.
1 Rockefeller Plaza, Suite 1039
New York, New York 10020
March 9, 2020
VIA
EDGAR
United
States Securities and Exchange Commission
100 F
Street, N.E.
Washington,
D.C. 20549
Attention:
Paul Fischer
Re: Hoth
Therapeutics, Inc.
Registration
Statement on Form S-3
File
No. 333-236887
Ladies and Gentlemen:
Pursuant to Rule 461
of the General Rules and Regulations under the Securities Act of 1933, as amended, Hoth Therapeutics, Inc. (the “Company”)
respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become
effective at 4:30 p.m., Eastern Standard Time, on Wednesday March 11, 2020, or as soon thereafter as possible.
Please notify Richard Friedman
of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 634-3031 as soon as possible as to the time
the Registration Statement has been declared effective pursuant to this acceleration request.
HOTH THERAPEUTICS, INC.
By:
/s/ Robb Knie
Name:
Robb Knie
Title:
Chief Executive Officer